Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Lancet
Main Authors: Parker, Chris C, Clarke, Noel W, Cook, Adrian D, Kynaston, Howard, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Saad, Fred, Bower, Lorna C, Logue, John, Payne, Heather, Forcat, Silvia, Goldstein, Cindy, Murphy, Claire, Anderson, Juliette, Barkati, Maroie, Bottomley, David M, Branagan, Jennifer, Choudhury, Ananya, Chung, Peter W M, Cogley, Lyn, Goh, Chee L, Hoskin, Peter, Khoo, Vincent, Malone, Shawn C, Masters, Lindsey, Morris, Stephen L, Nabid, Abdenour, Ong, Aldrich D, Raman, Rakesh, Tarver, Kathryn L, Tree, Alison C, Worlding, Jane, Wylie, James P, Zarkar, Anjali M, Parulekar, Wendy R, Parmar, Mahesh K B, Sydes, Matthew R
פורמט: Artigo
שפה:Inglês
יצא לאור: 2024
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616360/
https://ncbi.nlm.nih.gov/pubmed/38763154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(24)00548-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים